Navigation Links
Investigational Drug May Reduce Involuntary Movements in People With Parkinson's Disease
Date:4/12/2011

HONOLULU, April 12, 2011 /PRNewswire-USNewswire/ -- Results of the first randomized, placebo-controlled long-term clinical trial show the investigational drug safinamide may reduce dyskinesia or involuntary movements in mid-to-late stage Parkinson's disease. The findings will be presented as late-breaking research at the 63rd Annual Meeting of the American Academy of Neurology, April 9–16, 2011, in Honolulu.

"Our findings over a two-year treatment period suggest that taking safinamide in addition to levodopa and other dopaminergic treatments could help patients who continue to experience tremors and involuntary movement problems," said study author Ravi Anand, MD, a consultant with Newron Pharmaceuticals in Bresso, Italy. "These results are an important step forward in understanding how safinamide impacts patients with severe Parkinson's disease. Symptoms of Parkinson's disease, motor fluctuations and dyskinesia can greatly affect a person's daily living and quality of life."

For the two-year study, 669 patients with mid-to-late stage Parkinson's disease who were already taking levodopa and other dopaminergic treatments were given 50 or 100 milligrams of safinamide per day or a placebo pill. Scientists tested participant's movement ability using the United Parkinson's disease rating scale that measures activities such as tremor, speech, behavior, mood and daily activities including swallowing, dressing and walking. A specific tool measuring severity of dyskinesia (DRS) was used in addition as primary efficacy endpoint.

At the start of the study, patients who took the 50 milligram dose of safinamide had an average score of 3.9 compared to a score of 3.4 for those taking a placebo pill. Patients who took the 100 milligram dose had an average score of 3.7.

After two years, researchers discovered in a post-hoc analysis that safinamide at 100 milligrams a day on top of taking levodopa reduced dyskines
'/>"/>

SOURCE American Academy of Neurology
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710
2. Positive Phase 2 Results Reported with Boehringer Ingelheims Investigational HCV Protease Inhibitor in Both Previously Treated and Untreated Patients
3. FDA Accepts Investigational New Drug Application for ARI-3030MO; First in Man Clinical Trial to Begin During First Quarter of 2011
4. Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension
5. Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines
6. FDA Grants Orphan Drug Designation to Bayers Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors
7. Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Antheras Investigational Novel Peptibody Agent
8. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
9. FDA Clears GeNO LLCs Investigational New Drug Application for Clinical Trials With Its NITROSYL™ Inhaled Nitric Oxide System
10. VIDEO from Merck and Co., Inc available on thenewsmarket.com: In Phase III Study Mercks Investigational CETP Inhibitor Anacetrapib Met Safety and Efficacy Endpoints in Patients with CHD
11. GeNO LLC Submits Investigational New Drug Application for Its NITROsyl™ Inhaled Nitric Oxide System to Treat Chronic Pulmonary Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)...  Advanced Medical Isotope Corporation ("AMIC") (OTCQB:  ADMD), ... the development of brachytherapy devices and medical isotopes ... a Life Sciences Discovery Fund (LSDF) Proof of ... is the commercialization partner.  The award was made ... titled "Optimized Injectable Radiogels for High-dose Therapy of ...
(Date:12/19/2014)... HILL, N.C. , Dec. 19, 2014 /PRNewswire/ ... to optimize a product,s web presence to reflect ... Brand websites, in particular, must meet the needs ... regulations and culture. According to ... more than half of the participating companies averaged ...
(Date:12/19/2014)... and CARDIFF-BY-THE-SEA, Calif. ... (NASDAQ: SRNE ;  Sorrento), an oncology ... pain, and Conkwest, Inc., a privately-held immuno-oncology company ... Killer (NK) cell-line based therapy, announced today that ... to jointly develop next generation CAR-TNK™ (pronounced as ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 2Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 3Building a Best-in-Class Pharma Global Brand Website 2Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5
(Date:12/22/2014)... New York, NY (PRWEB) December 22, 2014 ... a noticeable toll and can present in the form ... nasolabail folds with the start of the marionette line ... peels, topical treatments and diligent skincare, but as the ... Radiesse, and Restylane are all synthetic fillers that can ...
(Date:12/22/2014)... Sagacious Consultants, the premier full-service Epic ... to their ad hoc report writing service to meet ... sign up for an annual subscription and get a ... a deeply discounted hourly rate. , Customers can ... progressively discounted rate. Subscription hours are contracted in 25 ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 The holidays are ... of the season. Many may be thinking about how to ... of a few weeks. Health Republic Insurance of New York ... Dietitian, Andrea Chernus, to provide some smart ideas to enjoy ... healthy. , 1)    Avoid arriving at a holiday gathering over-hungry , ...
(Date:12/22/2014)... new vaccine created to fight an illness similar to ... and even humans from similar brain infections, researchers report. ... becoming infected by the incurable brain disorder known as ... Dec. 21 online edition of the journal Vaccine ... particles known as prions that go rogue. Prion ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Super Saturday, ... Friday this year as the busiest day in the ... retailers, The Grass Station had a steady pre-Christmas stream ... gifts, this past Saturday. , “I definitely intend to ... Robert, a Denver resident who was enjoying The Grass ...
Breaking Medicine News(10 mins):Health News:Sam Rizk, MD, FACS, Introduces Rapid Recovery Facelift 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 3Health News:Health Republic Insurance of New York Offers Five Simple Tips to Eat Healthy During the Holidays 2Health News:Vaccine for Deer Against 'Mad Cow'-Like Illness Shows Promise 2Health News:Customers at Colorado’s Grass Station Say They’re Enjoying the Experience of Legally Purchasing Marijuana this Year to Give as Christmas Presents to Friends and Family 2
... , JACKSONVILLE, Fla., Aug. 18 ... Blue Cross and Blue Shield of Florida (BCBSF), announced today that ... receive funding from Partners Investing in Nursing,s Future , a ... nurses across the country. To date, this is the first Florida ...
... , New data show nanotechnology-related ... , WASHINGTON, Aug. 18 Every state can ... Data released today by the Project on Emerging Nanotechnologies ... organizations across all 50 U.S. states and in the District of ...
... , EDISON, N.J., Aug. 18 Digitek Medication ... various heart conditions, such as abnormal heart rhythms (atrial fibrillation & atrial ... potent that even a slight increase in dosage can be toxic or ... has suffered digitalis toxicity or symptoms associated with digitalis toxicity as a ...
... disordered breathing to deadly cardiovascular complications , TUESDAY, ... sleep apnea -- loud snoring, interrupted breathing and sleep ... and premature death among middle-aged and elderly men, according ... moderate sleep apnea face an increased death risk, as ...
... 10 physician groups in national experiment, U-M Faculty Group Practice demonstrates ... , ANN ARBOR, Mich., Aug. 18 Medicare patients ... getting better treatment than ever at the University of Michigan Health ... report. , , These results come from ...
... , , , , ... Mobility Solutions business of Motor o la, ... Motorola AirDefense Wireless Vulnerability Assessment solution , a ... networks. This innovative solution provides a completely new method to secure ...
Cached Medicine News:Health News:The Blue Foundation for a Healthy Florida Receives Grant to Address National/Regional Nursing Shortages 2Health News:The Blue Foundation for a Healthy Florida Receives Grant to Address National/Regional Nursing Shortages 3Health News:The Blue Foundation for a Healthy Florida Receives Grant to Address National/Regional Nursing Shortages 4Health News:The Blue Foundation for a Healthy Florida Receives Grant to Address National/Regional Nursing Shortages 5Health News:Putting Nanotechnology on the Map 2Health News:Putting Nanotechnology on the Map 3Health News:Digitek Medication Recalled Due to Risk of Digitalis Toxicity 2Health News:Sleep Apnea Raises Risk of Death, Especially for Men: Report 2Health News:Sleep Apnea Raises Risk of Death, Especially for Men: Report 3Health News:Sleep Apnea Raises Risk of Death, Especially for Men: Report 4Health News:U-M Improved Preventive and Chronic Care and Saved Medicare $$ 2Health News:U-M Improved Preventive and Chronic Care and Saved Medicare $$ 3Health News:U-M Improved Preventive and Chronic Care and Saved Medicare $$ 4Health News:Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing 2Health News:Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing 3Health News:Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing 4Health News:Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing 5
... Accutest H. pylori WB test ... the qualitative detection of lgG ... in human whole blood. This ... an aid in the diagnosis ...
... is an FDA approved rapid ... blood test used to aid ... infection. This CLIA waived test, ... antibodies to HIV-1, requires only ...
... QuickVue+ Infectious Mononucleosis test is ... antibodies in serum, plasma or whole ... utilizes an extract of bovine erythrocytes ... specificity than similar extracts prepared from ...
... the first available point-of-care diagnostic test that ... of influenza A and B. The test ... an enzyme that assists viral replication by ... infected cells. The ZstatFlu substrate is labeled ...
Medicine Products: